PD-L1 on immune cells or tumor cells can interact with the co-inhibitory PD-1 receptor on T cells to attenuate T cell function [39], and PD-L1 expression can predict checkpoint inhibitor (anti-PD-L1) efficacy [40]. Here, CD274 is linked to neoplasm.